Scholarly record
ORIGINAL DRUGS VS GENERICS. THE INFLUENCE OF MARKETING AND PUBLIC RELATIONS
Abstract
The Pharmaceutical Industry is one of the biggest industries trying to balance the relationships between innovation, competition and superior profits [1]. As we noticed, nowadays, we have many types of drugs at our disposal to buy. But what happens when many pharmaceutical manufacturers produce the same drug, with the same active substances, changing just the appealing packaging? People barely notice and, of course, they pay more for the same original drug that they used to buy. How rapidly new drugs appear on market is and interesting point of discussion since all major aspects of drug testing and regulation include pre-clinical animal tests, clinical trials and postmarketing surveillance of adverse drug reactions [2]. This paper is aimed to explain the differences between some original drugs and generics sold in Romania and how marketing influences people choices when buying drugs and other health care products.
Publication Impact Profile
Publication details
References11
US Food and Drug Administration. What are generic drugs? Available at: https://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/UnderstandingGenericDrugs/default.htm;
Pawel L., Przemyslaw K., Generic drugs: The benefits and risks of making the switch, The Journal of Family Practice, Vol. 59, No. 11, pp. 634-640, 2010;
Karan B. T., Gauri B., The concept of: Generic drugs and patented drugs vs. brand name drugs and non-proprietary (generic) name drugs, Frontiers in Pharmacology, 4:113, 2013;
Peters JR, Hixon DR, Conner DP, et al. Generic drugs—safe, effective, and aff ordable. Dermatol Th er. 2009;22:229-240
World Health Organization. Multi-source pharmaceutical products: WHO guideline on registration requirements to establish interchangeability. WHO Technical Support Series. Geneva, Switzerland: WHO;1996:TRS 863
Meyer MC. Generic drug product equivalence: current status. Am J Manag Care. 1998;4:1183-1189
Calvert RT. Bioequivalence and generic prescribing: a pharmacy view. J Pharm Pharmacol. 1996;48:9-10
British National Formulary: No. 31. London, England: Pharmaceutical Press; 1996
Campbell E. G. et. al., Physician Acquiescence to Patient Demands for Brand-Name Drugs: Results of a National Survey of Physicians, JAMA Intern Med., 173(3), pp. 237-239, 2013; Roberts P. W., Product innovation, product-market competition and persistent profitability in the US pharmaceutical industry, Strategic Management Journal, vol. 20(7), 1999, pp 655-670; Abraham J., Politics And The Pharmaceutical Industry: Controversy And Bias In Drug Regulation, Science, Technology, & Human Values, vol. 21/issue 4, pp. 487-489, 1996
Wilcox, D. L., & Cameron, G. T. Public Relations: Strategies and Tactics. Boston, MA: Pearson Education, Inc. (2009)
PRSA. What is Public Relations?, Public Relations Society of America
View or Download full articleAccess options
SWS access login
Login as SWS Scientific CommitteeLogin as SWS Scientific PartnerLogin as SWS AuthorAuthors and approved SWS contributors will read and export their own linked papers after identity matching by SWS profile, email and SGEM GlobalID.
For librarian assistance: [email protected]
Purchase Instant Access
- Article can be downloaded after successful payment.
- Article may be used according to SWS library access terms.
- Article cannot be redistributed.
